Jerry has over a decade of experience in the patent profession, specialising in chemical and mechanical technologies, with experience of medical device, chemical formulation, solid state and process chemistries, composites and other materials cases. As well as drafting and prosecuting patent applications, he provides FTO and strategic IP advice and handles oppositions and other oral proceedings before the EPO.
He has a broad range of expertise dealing with medical devices, including pulse oximetry, laryngoscopy and latterly a wide range of transcatheter devices. Jerry’s practice also includes chemical and materials technologies, renewable energy and petrochemical technologies, aerospace and composites technologies, and hydraulic and pneumatic systems.
Jerry spent time in industrial R&D and university technology transfer, before joining the patent profession in 2007.
Jerry has extensive experience of drafting and prosecuting applications before the EPO and UKIPO, and managing international patent portfolios. In addition, he has advised his clients on patent infringement and validity, and assisted in due diligence on behalf of his clients.
Jerry holds a first class M. Chem from the University of Oxford and went on to obtain a PhD from the University of British Columbia, Vancouver, Canada, in the field of solid state NMR spectroscopy.
On returning to the UK Jerry spent time in industrial R&D and university technology transfer, before joining the patent profession in 2007. He moved to the Edinburgh office of HGF in September 2015, from another top-tier UK firm.
University of Oxford
University of British Columbia
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.